Cardiac ArrestNCT06552312
A Modified Delphi for ECPR Post Resuscitation Care
An observational study of Cardiac Arrest, run by Sydney Local Health District at 1 site in Australia.
Trial summary
The objective of this study is to generate expert consensus statements on the management of out of hospital cardiac arrest (OHCA) patients treated with extracorporeal membrane oxygenation (ECMO) cardiopulmonary resuscitation (ECPR). Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Cardiac Arrest
- What is being tested?
- Delphi Questionnaire
- How many people
- 50 participants
- Where
- 1 siteAustralia
- Study dates
- 30 Oct 2024to 30 Oct 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Internationally recognised experts in extracorporeal membrane oxygenation cardiopulmonary resuscitation (ECPR) and Out of Hospital Cardiac Arrest (OHCA).
Who may be able to join
- Identified experts on ECPR for OHCA based on contributions to the field, clinical experiences, range of specialties and peer-reviewed publications with prioritization of diversity in geography and expertise. Using snowball sampling, we asked the recruited experts to identify additional content experts to participate in the expert panel. We will aim to recruit a total of 50 experts, in accordance with the recommended panel number of >30 as outlined in the original Delphi method paper.
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: ECPR Post Resuscitation Care an International Consensus Statement Via Modified Delphi Approach
The objective of this study is to generate expert consensus statements on the management of out of hospital cardiac arrest (OHCA) patients treated with extracorporeal membrane oxygenation (ECMO) cardiopulmonary resuscitation (ECPR).
Read the detailed description
The study will be performed using a modified Delphi process with an international expert panel to generate recommendation statements related to the management of patients treated with ECPR and to determine the level of agreement for each statement from the panel as a whole. The following topics will be covered:
Sedation Mechanical ventilation management Oxygen management Carbon dioxide management Haemodynamic management ECMO flow management Mean arterial pressure targets Aortic valve not opening management Left ventricular unloading/venting Complication management Infection prevention Anticoagulation Imaging Prognostication and neuro-prognostication Practical recommendations Organ donation Patient followup
Cannulation will not be covered as this has been covered in other Delphi processes.
Management Consensus is achieved through iterative rounds of survey and revision to the statements until a pre-determined level of agreement is met (>70% agreement).
Part 1: planning and evidence review Series of planning sessions with co-chairs Literature is reviewed/summarized Initial statements will be developed based on evidence and study team expertise
Expert panel selection:
The study team identified experts on ECPR for OHCA based on contributions to the field, clinical experiences, range of specialties and peer-reviewed publications with prioritization of diversity in geography and expertise. Using snowball sampling, investigators will ask the recruited experts to identify additional content experts to participate in the expert panel. It is aimed to recruit a total of 50 experts, in accordance with the recommended panel number of >30 as outlined in the original Delphi method paper. To avoid any bias, the study team will not participate in the voting process. The survey and voting process will be online and anonymous to avoid any reciprocal influence.
Part 2: Survey to achieve consensus Survey, based on the initial statements developed by study team, will be developed. This will be reviewed by independent contributors (not part of the study team or the expert panel), to ensure validity, appropriate topic coverage and length.
Some questions will enable a Yes/No or quantitative response. Others will be utilising a Likert scale. The voting process will be anonymous to avoid any reciprocal influence or dredging effects and done with Research and Development/University of California, Los Angeles (RAND/UCLA) Appropriateness Method Scale.
Experts will be asked to rate the importance of each item for ECPR for OHCA using the Grading of Recommendations Assessment, Development and evaluation scale from 1 (strongly disagree) to 9 (strongly agree). Statements will be classified as strong agreement (median score 7-9), neither agree or disagree (median score 4-6), or strongly disagree (median score 1-3). Panel members will also provided an "Unable to Score" response to use if they did not feel comfortable rating any specific domain. Recipients will be asked to recommend any wording/phrasing changes and to suggest any additional items for inclusion.
Based on a previously established Delphi method approach, consensus will be achieved when an item reached a high level of agreement for inclusion. High level of agreement will require greater than 70% of the survey responses for a particular item meeting a score of strong agreement (i.e. a score ≥ 7 on the Likert scale). A medium level of agreement will be defined between 60% and 70%, and low agreement below 60%. Each expert will receive anonymized aggregate statistics (group mean, group standard deviation, percentage agreement). Statements achieving a high level of agreement in the first survey (i.e. a score of 70% of respondents with a score >7) will not be reviewed in the consensus meeting nor in the second survey. Those not meeting a high level of agreement will be rephased during the online meeting or subsequent surveys. If 70% of respondents score a statement at 3 (on the 9-point scale) or less for a statement in the first-round survey, that statement will be deemed not important and removed and not discussed at the online discussion.
An online consensus meeting will be arranged after the first round where the expert panel will discuss the items in detail, including comments on the first survey. Modifications to questions will be possible at this meeting.
Following the online consensus meeting, additional survey rounds will be prepared and sent to each expert as determined by the study group. This survey will include each item with comments indicating changes made during the consensus meeting as well as the mean score and level of agreement (low, medium, high) for each item from the first survey (excluding statements of low importance/agreement as defined above). Expert participants will again rate each item on the same 9-point Likert scale. Descriptive statistics including median, IQR, and level of agreement will be obtained for each item from the final survey. Items that reach a high level of agreement will be included in the final list of consensuses. Items that reached medium or low agreement will be discarded after the final round but will be provided as supplementary data for review.
It is anticipated that 3 rounds of the Delphi process will be required. Additional rounds may be considered if the study group and expert group view additional consensus may be made on key items with restructuring of statements.
The percentage agreement will be quantified as the number of individual scores of more than 7 divided by the number of voting experts. Given the poor- and low-quality data available on many aspects of topic, the study team will not be using the Grading of Recommendation Assessment Development and Evaluation (GRADE) to prepare statements but will referrer to the Appraisal of Guidelines for Research and evaluation (AGREE) statement. This approach is consistent with other recently published guidelines.
- Conditions
- Cardiac Arrest
- Being tested
- Delphi Questionnaire
- Keywords
- Extracorporeal membrane oxygenation (ECMO), Extracorporeal membrane oxygenation cardiopulmonary resuscitation (ECPR)
- Medical subject headings
- Heart Arrest
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Delphi QuestionnaireOther
Experts will be asked to rate the importance of each item for ECPR for OHCA using the Grading of Recommendations Assessment, Development and evaluation scale from 1 (strongly disagree) to 9 (strongly agree). Statements will be classified as strong agreement (median score 7-9), neither agree or disagree (median score 4-6), or strongly disagree (median score 1-3). Panel members were also provided an "Unable to Score" response to use if they did not feel comfortable rating any specific domain. Recipients will be asked to recommend any wording/phrasing changes and to suggest any additional items for inclusion.
| Study group | Role | What they receive |
|---|---|---|
| Delphi Panel | The Delphi panel will include between 20-50 international experts in critical care, cardiology, intensive care, anaesthesia, emergency medicine, perfusion and cardio-thoracic surgery. Receives: Other: Delphi Questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
Degree of consensus
The level of agreement for all statements achieving consensus from the expert panel; consensus is predefined as ≥ 70% of the panel rating a given statement >7 on a likert scale between 1-9
Measured: Six months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Aug 2024
- Study start30 Oct 2024
- Primary completion30 Sep 2025 (estimated)
- Study completion30 Oct 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Cardiac ArrestStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sydney Local Health District
- Sponsor type
- Other government
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06552312
- Sponsor's protocol ID
- TBA
- Status last verified
- May 2025
- First submitted
- 10 Aug 2024
- Last updated
- 18 May 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Dennis M, Supady A, Abrams D, Bartos J, Jung JS, Kruit N, Ling S, Rosenberg A, Sackley M, Scquizzato T, Burrell A; with the Critical CAre after Resuscitative Ecmo (CARES) Expert panel dagger. Recommendations in Extracorporeal Cardiopulmonary Resuscitation Post Resuscitation Care Via An International, Modified Delphi Approach. J Am Heart Assoc. 2026 Feb 17;15(4):e047548. doi: 10.1161/JAHA.125.047548. Epub 2026 Feb 12.
PubMed 41676946
Study at a glance
From the registry record, last updated by the sponsor on 18 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- ECPR Post Resuscitation Care an International Consensus Statement Via Modified Delphi Approach
- ClinicalTrials.gov ID
- NCT06552312
- Acronym / sponsor ID
- TBA
- Conditions
- Cardiac Arrest
- Keywords
- Extracorporeal membrane oxygenation (ECMO), Extracorporeal membrane oxygenation cardiopulmonary resuscitation (ECPR)
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Sydney Local Health DistrictOther government
- Study start
- 30 Oct 2024 (actual)
- Primary completion
- 30 Sep 2025 (estimated)
- Study completion
- 30 Oct 2025 (estimated)
- First posted
- 14 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of this study is to generate expert consensus statements on the management of out of hospital cardiac arrest (OHCA) patients treated with extracorporeal membrane oxygenation (ECMO) cardiopulmonary resuscitation (ECPR).
Detailed description
The study will be performed using a modified Delphi process with an international expert panel to generate recommendation statements related to the management of patients treated with ECPR and to determine the level of agreement for each statement from the panel as a whole. The following topics will be covered:
Sedation Mechanical ventilation management Oxygen management Carbon dioxide management Haemodynamic management ECMO flow management Mean arterial pressure targets Aortic valve not opening management Left ventricular unloading/venting Complication management Infection prevention Anticoagulation Imaging Prognostication and neuro-prognostication Practical recommendations Organ donation Patient followup
Cannulation will not be covered as this has been covered in other Delphi processes.
Management Consensus is achieved through iterative rounds of survey and revision to the statements until a pre-determined level of agreement is met (>70% agreement).
Part 1: planning and evidence review Series of planning sessions with co-chairs Literature is reviewed/summarized Initial statements will be developed based on evidence and study team expertise
Expert panel selection:
The study team identified experts on ECPR for OHCA based on contributions to the field, clinical experiences, range of specialties and peer-reviewed publications with prioritization of diversity in geography and expertise. Using snowball sampling, investigators will ask the recruited experts to identify additional content experts to participate in the expert panel. It is aimed to recruit a total of 50 experts, in accordance with the recommended panel number of >30 as outlined in the original Delphi method paper. To avoid any bias, the study team will not participate in the voting process. The survey and voting process will be online and anonymous to avoid any reciprocal influence.
Part 2: Survey to achieve consensus Survey, based on the initial statements developed by study team, will be developed. This will be reviewed by independent contributors (not part of the study team or the expert panel), to ensure validity, appropriate topic coverage and length.
Some questions will enable a Yes/No or quantitative response. Others will be utilising a Likert scale. The voting process will be anonymous to avoid any reciprocal influence or dredging effects and done with Research and Development/University of California, Los Angeles (RAND/UCLA) Appropriateness Method Scale.
Experts will be asked to rate the importance of each item for ECPR for OHCA using the Grading of Recommendations Assessment, Development and evaluation scale from 1 (strongly disagree) to 9 (strongly agree). Statements will be classified as strong agreement (median score 7-9), neither agree or disagree (median score 4-6), or strongly disagree (median score 1-3). Panel members will also provided an "Unable to Score" response to use if they did not feel comfortable rating any specific domain. Recipients will be asked to recommend any wording/phrasing changes and to suggest any additional items for inclusion.
Based on a previously established Delphi method approach, consensus will be achieved when an item reached a high level of agreement for inclusion. High level of agreement will require greater than 70% of the survey responses for a particular item meeting a score of strong agreement (i.e. a score ≥ 7 on the Likert scale). A medium level of agreement will be defined between 60% and 70%, and low agreement below 60%. Each expert will receive anonymized aggregate statistics (group mean, group standard deviation, percentage agreement). Statements achieving a high level of agreement in the first survey (i.e. a score of 70% of respondents with a score >7) will not be reviewed in the consensus meeting nor in the second survey. Those not meeting a high level of agreement will be rephased during the online meeting or subsequent surveys. If 70% of respondents score a statement at 3 (on the 9-point scale) or less for a statement in the first-round survey, that statement will be deemed not important and removed and not discussed at the online discussion.
An online consensus meeting will be arranged after the first round where the expert panel will discuss the items in detail, including comments on the first survey. Modifications to questions will be possible at this meeting.
Following the online consensus meeting, additional survey rounds will be prepared and sent to each expert as determined by the study group. This survey will include each item with comments indicating changes made during the consensus meeting as well as the mean score and level of agreement (low, medium, high) for each item from the first survey (excluding statements of low importance/agreement as defined above). Expert participants will again rate each item on the same 9-point Likert scale. Descriptive statistics including median, IQR, and level of agreement will be obtained for each item from the final survey. Items that reach a high level of agreement will be included in the final list of consensuses. Items that reached medium or low agreement will be discarded after the final round but will be provided as supplementary data for review.
It is anticipated that 3 rounds of the Delphi process will be required. Additional rounds may be considered if the study group and expert group view additional consensus may be made on key items with restructuring of statements.
The percentage agreement will be quantified as the number of individual scores of more than 7 divided by the number of voting experts. Given the poor- and low-quality data available on many aspects of topic, the study team will not be using the Grading of Recommendation Assessment Development and Evaluation (GRADE) to prepare statements but will referrer to the Appraisal of Guidelines for Research and evaluation (AGREE) statement. This approach is consistent with other recently published guidelines.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Delphi Panel | – | Other: Delphi QuestionnaireThe Delphi panel will include between 20-50 international experts in critical care, cardiology, intensive care, anaesthesia, emergency medicine, perfusion and cardio-thoracic surgery. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Internationally recognised experts in extracorporeal membrane oxygenation cardiopulmonary resuscitation (ECPR) and Out of Hospital Cardiac Arrest (OHCA).
Key inclusion criteria (1 listed)
- Identified experts on ECPR for OHCA based on contributions to the field, clinical experiences, range of specialties and peer-reviewed publications with prioritization of diversity in geography and expertise. Using snowball sampling, we asked the recruited experts to identify additional content experts to participate in the expert panel. We will aim to recruit a total of 50 experts, in accordance with the recommended panel number of >30 as outlined in the original Delphi method paper.
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Delphi QuestionnaireExperts will be asked to rate the importance of each item for ECPR for OHCA using the Grading of Recommendations Assessment, Development and evaluation scale from 1 (strongly disagree) to 9 (strongly agree). Statements will be classified as strong agreement (median score 7-9), neither agree or disagree (median score 4-6), or strongly disagree (median score 1-3). Panel members were also provided an "Unable to Score" response to use if they did not feel comfortable rating any specific domain. Recipients will be asked to recommend any wording/phrasing changes and to suggest any additional items for inclusion. | Other | Delphi Panel |
Primary outcome
Degree of consensus
Time frame: Six months
The level of agreement for all statements achieving consensus from the expert panel; consensus is predefined as ≥ 70% of the panel rating a given statement >7 on a likert scale between 1-9
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 May 2025.
- Derived from this study: PubMed 41676946Dennis M, Supady A, Abrams D, Bartos J, Jung JS, Kruit N, Ling S, Rosenberg A, Sackley M, Scquizzato T, Burrell A; with the Critical CAre after Resuscitative Ecmo (CARES) Expert panel dagger. Recommendations in Extracorporeal Cardiopulmonary Resuscitation Post Resuscitation Care Via An International, Modified Delphi Approach. J Am Heart Assoc. 2026 Feb 17;15(4):e047548. doi: 10.1161/JAHA.125.047548. Epub 2026 Feb 12.
Related trials for Cardiac Arrest
Recruiting
Minimal Sedation Versus Standard Continuous Sedation After Out-of-Hospital Cardiac Arrest
Out-of-Hospital Cardiac Arrest, Hypoxic-Ischemic Brain Injury
RecruitingObservational study
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Chronic Lymphocytic Leukemia (CLL), Waldenstr(SqrRoot)(Delta)m s Macroglobulinemia
Not yet recruiting
Sustained Inflation and Chest Compression vs 3:1 C:V Ratio in Asphyxiated Newborns
Cardiac Arrest
Recruiting
The VENTOR Clinical Study
Cardiac Arrest (CA)
RecruitingObservational study
Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest
Cardiac Arrest (CA)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cardiac Arrest, run by Sydney Local Health District at 1 site in Australia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 18 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Degree of consensus (time frame: Six months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06552312, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2025.